JPRN-UMIN000051464
Completed
未知
PolyMyXin-B direct hemoperfusion OPTimal Initiation timing with Catecholamine study (PMX-OPTIC study) - PMX-OPTIC study
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Teikyo University
- Enrollment
- 600
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Cases of End of Life/Terminal Care where treatment was not the primary objective. 2\. Patients who received interventions for circulatory support such as ECMO, VAD, IMPELLA (excluding IABP).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
The effects of polymyxin B hemoperfusion on extra vascular lung water and pulmonary vascular permeabilityJPRN-UMIN000014546Yokohama City University10
Terminated
Not Applicable
Efficacy of Polymyxin B Hemoperfusion on Severe Sepsis Secondary to Pneumonia or Urinary Tract InfectionSepsisNCT02871024National Taiwan University Hospital1
Temporarily Not Available
Not Applicable
Open-label Evaluation of Polymyxin B Hemoperfusion for Septic ShockSeptic ShockEndotoxemiaNCT02825329Spectral Diagnostics (US) Inc.
Completed
Phase 3
The Effects of Polymyxin-B Protects on Sepsis Induced Kidney Dysfunction: a Randomized Clinical TrialGram-Negative Bacterial InfectionsSepsisNCT00490477University of Turin, Italy16
Completed
Not Applicable
Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Septic ShockSeptic ShockEndotoxemiaNCT01046669Spectral Diagnostics (US) Inc.450